- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02746484
ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care Program
ABILITY - TelerehABILITation. TechnologY-enhanced Multi-domain at Home Continuum of Care Program for People With Cognitive Impairment.
The Ability research project, funded in Italy within the Smart Cities and Smart Communities funding program (MInistry of University and Research, Operational Regional Programme, Lombardy, Axis 1, Operational Regional Programme - European Funding for Regional Development 2007-2013), aims at developing and testing the efficacy and the impact of a Personal Smart Health Community able to provide innovative trajectories for people with cognitive impairment, putting them at the core of a continuous and intertwining treatment and support from both formal (e.g. physicians) and informal (e.g. near relatives) caregivers, with special focus on home-based care.
Within this framework of the Ability project the investigators test the efficacy of the home-based motor-cognitive rehabilitation program delivered with two different approaches: the Ability platform versus the usual care program
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- diagnosed as mild AD or MCI due to AD (Albert et al, 2011) according to DSM 5 diagnostic criteria (American Psychiatric Association, 2013);
- MMSE score >18
- school attendance (≥ 3 years).
Exclusion Criteria:
- dysmetria;
- serious deficits in visual acuity, acoustic perception, and in routine communication skills.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Ability platform program
Multi-domain at home rehabilitation program delivered through the Ability platform.
|
The Ability program is an at home participant-tailored and technology-enhanced platform a) delivering tablet-based intensive (five days/a week for six weeks) motor and cognitive activities; b) monitoring from remote vital and physical health parameters (i.e., weight, Heart Rate, O2 saturation, daily steps, sleep activity).
|
Active Comparator: Usual care program
Usual care at home program (paper and pencil cognitive activities; promotion of physical activity according to healthcare professional's advice)
|
Usual care at home program (paper and pencil cognitive activities; promotion of physical activity according to healthcare professional's advice)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
activities of daily living
Time Frame: change from baseline after 8 weeks (aMCI/AD subjects)
|
Activities of Daily Living Inventory (ADCS/ADL)
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
behavioral symptoms
Time Frame: change from baseline after 8 weeks (aMCI/AD subjects)
|
Neuropsychiatric Inventory (NPI) score
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
cognitive domain (long-term memory)
Time Frame: change from baseline after 8 weeks (aMCI/AD subjects)
|
Free and Cued Selective Recall Test (FCSRT) score
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
cognitive domain (language)
Time Frame: change from baseline after 8 weeks (aMCI/AD subjects)
|
Fluency score
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
cognitive domain (frontal-executive functions)
Time Frame: change from baseline after 8 weeks (aMCI/AD subjects)
|
Trail Making Test (TMT) score
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
quality of life
Time Frame: change from baseline after 8 weeks (aMCI/AD subjects)
|
Dementia Quality of Life (D-QoL) Instrument
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
coping strategies
Time Frame: change from baseline after 8 weeks (aMCI/AD subjects)
|
Coping Orientation for Problems Experienced - Brief Version (Brief COPE)
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
global cognitive level
Time Frame: change from baseline after 12 months (aMCI/AD subjects)
|
Montreal Cognitive Asssessment (MoCA) score
|
change from baseline after 12 months (aMCI/AD subjects)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
activities of daily living
Time Frame: change from baseline after 12 months (aMCI/AD subjects)
|
Activities of Daily Living Inventory (ADCS/ADL)
|
change from baseline after 12 months (aMCI/AD subjects)
|
conversion rate MCI versus AD
Time Frame: change from baseline after 12 months (aMCI subjects)
|
conversion rate score
|
change from baseline after 12 months (aMCI subjects)
|
cognitive domain - long term memory
Time Frame: change from baseline after 12 months (aMCI/AD subjects)
|
Free and Cued Selective Recall Test (FCSRT) score
|
change from baseline after 12 months (aMCI/AD subjects)
|
cognitive domain - language
Time Frame: change from baseline after 12 months (aMCI/AD subjects)
|
Fluency score
|
change from baseline after 12 months (aMCI/AD subjects)
|
cognitive domain - frontal executive functions
Time Frame: change from baseline after 12 months
|
Trail Making Test (TMT) score
|
change from baseline after 12 months
|
quality of life
Time Frame: change from baseline after 12 months
|
Dementia Quality of Life (D-QoL) Instrument
|
change from baseline after 12 months
|
coping strategies
Time Frame: change from baseline after 12 months
|
Coping Orientation for Problems Experienced - Brief Version (Brief COPE)
|
change from baseline after 12 months
|
caregiver quality of life
Time Frame: change from baseline after 8 weeks and after 12 months
|
Psychological Well-Being (PWB) scale
|
change from baseline after 8 weeks and after 12 months
|
caregiver coping strategies
Time Frame: change from baseline after 8 weeks and after 12 months
|
Coping Orientation for Problems Experienced - Brief Version (Brief COPE)
|
change from baseline after 8 weeks and after 12 months
|
caregiver burden
Time Frame: change from baseline after 8 weeks and after 12 months
|
Caregiver Burden Inventory (CBI)
|
change from baseline after 8 weeks and after 12 months
|
caregiver affect
Time Frame: change from baseline after 8 weeks and after 12 months
|
Positive and Negative Affect Schedule (PANAS)
|
change from baseline after 8 weeks and after 12 months
|
Collaborators and Investigators
Collaborators
Publications and helpful links
General Publications
- Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011 May;7(3):270-9. doi: 10.1016/j.jalz.2011.03.008. Epub 2011 Apr 21.
- Realdon O, Rossetto F, Nalin M, Baroni I, Cabinio M, Fioravanti R, Saibene FL, Alberoni M, Mantovani F, Romano M, Nemni R, Baglio F. Technology-enhanced multi-domain at home continuum of care program with respect to usual care for people with cognitive impairment: the Ability-TelerehABILITation study protocol for a randomized controlled trial. BMC Psychiatry. 2016 Nov 25;16(1):425. doi: 10.1186/s12888-016-1132-y.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FdG_AD_02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityRecruitingDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeRecruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Cognito Therapeutics, Inc.Enrolling by invitationExtension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)Cognitive Impairment | Alzheimer Disease | Mild Cognitive Impairment | Dementia Alzheimers | Dementia of Alzheimer Type | AD | Dementia, Mild | Dementia ModerateUnited States
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
-
University College, LondonNot yet recruitingDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal | DEM
-
University College, LondonThe University of Hong KongUnknownDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal
-
Karolinska InstitutetRegion Stockholm; KTH Royal Institute of TechnologyActive, not recruitingAlzheimer Dementia | Dementia DisordersSweden
Clinical Trials on Ability platform program
-
The University of QueenslandRestorative Outcomes Australia; Department of Education, Queensland; Queensland... and other collaboratorsUnknownAntisocial Behavior | School Attendance | Welfare DependenceAustralia
-
University of SalamancaNot yet recruiting
-
University of CalgaryRecruitingParent-Child RelationsCanada
-
Massachusetts General HospitalNational Institute on Aging (NIA)Not yet recruitingPhysical Activity
-
University of PittsburghAgency for Healthcare Research and Quality (AHRQ)TerminatedHeart FailureUnited States
-
hanaa mohsenCompletedVestibular RehabilitationEgypt
-
Kaohsiung Medical University Chung-Ho Memorial...Completed
-
Uppsala UniversityThe Swedish Research Council; Uppsala University Hospital; Uppsala County Council... and other collaboratorsTerminated
-
Duke UniversityCompletedType 2 DiabetesUnited States
-
University of ValenciaMinisterio de Ciencia e Innovación, SpainRecruitingIntervention on Socio-emotional Development and Well-being Through ICTs in Early Adulthood (EMOWELL)Emotion RegulationSpain